What is Histrelin Acetate?

Histrelin Acetate is a nonapeptide analog of gonadotropin-releasing hormone (GnRH) with added potency. When present in the bloodstream, it acts on accurate beef of the pituitary gland alleged gonadotropes. Histrelin stimulates these beef to absolution luteinizing hormone and follicle-stimulating hormone. Thus it is advised a gonadotropin-releasing hormone agonist or GnRH agonist.
Histrelin is marketed by Endo Pharmaceuticals beneath the cast names Vantas and Supprelin LA.
Histrelin is a man-made version of a hormone that is similar to the one normally released from the hypothalamus gland in the brain. It works in the brain to reduce the blood levels of sex hormones, such as testosterone and estrogen. The histrelin implant is placed under the skin. The implant releases small amounts of histrelin in the body every day for 12 months.
Histrelin is used to treat advanced prostate cancer in adults. It will reduce the level of testosterone, a male hormone, in the blood. Testosterone makes most prostate cancers grow. Histrelin is not a cure for prostate cancer, but it may help relieve the symptoms.
Histrelin Acetate is a potent LHRH (GnRH) agonist. After a transient increase, continuous administration of histrelin results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis.
More about: Histrelin Acetate sale
Read more: Peptides

Where to get Histrelin Acetate?

Histrelin Acetate is a nonapeptide analog of gonadotropin-releasing hormone (GnRH) with added potency. When present in the bloodstream, it acts on particular cells of the pituitary gland called gonadotropes. Histrelin stimulates these cells to release luteinizing hormone and follicle-stimulating hormone. Thus it is considered a gonadotropin-releasing hormone agonist or GnRH agonist.
Histrelin is marketed by Endo Pharmaceuticals under the brand names Vantas and Supprelin LA.
Histrelin Acetate is a potent LHRH (GnRH) agonist. After a transient increase, continuous administration of histrelin results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis.
Indications
Histrelin is used to treat hormone-sensitive cancers of the prostate in men and uterine fibroids in women. In addition, histrelin has been proven to be highly effective in treating central precocious puberty in children.
It is available as a daily intramuscular injection.
Histrelin is also available in a 12-month subcutaneous implant (Vantas) for the palliative treatment of advanced prostate cancer.
A 12-month subcutaneous implant (Supprelin LA) for central precocious puberty (CPP) was approved on May 3, 2007 by the U.S. Food and Drug Administration.
More about: Histrelin Acetate sale
Read more: Peptides